Hepcidin inhibits hepatocyte apoptosis through the PERK pathway in acute liver injury and fibrosis
Hepcidin inhibits hepatocyte apoptosis through suppression of the PERK pathway, highlighting its protective role in liver fibrosis and identifying a potential therapeutic target for the treatment of liver fibrosis.
Authors
- Changying Li (ORCID: https://orcid.org/0000-0002-0115-7507)
- Tianhui Liu (ORCID: https://orcid.org/0000-0001-6789-3016)
- Xinyan Zhao (ORCID: https://orcid.org/0000-0002-8016-4368)
- Xiaoli Huang (ORCID: https://orcid.org/0000-0001-9628-5618)
- Wei Chen (ORCID: https://orcid.org/0009-0009-0262-5964)
- Min Cong (ORCID: https://orcid.org/0000-0003-0188-3661)
- Yingying Liu (ORCID: https://orcid.org/0009-0002-6697-9306)
- Ping Wang (ORCID: https://orcid.org/0000-0002-1395-2014)
- Ming Gao (ORCID: https://orcid.org/0000-0001-7892-8050)
- Weihua Zhao
- Xu Fan (ORCID: https://orcid.org/0009-0008-3063-7201)
- G Pang
Institutions
- Capital Medical University (CN)
- Chinese Academy of Sciences (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Research Center for Eco-Environmental Sciences (CN)
- Beijing Friendship Hospital (CN)
- Beijing Hua Xin Hospital (CN)
- University of Chinese Academy of Sciences (CN)
Publication Details
- Journal
- Hepatology Communications
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1097/hc9.0000000000000604
- Citations
- 2
- Primary Topic
- Iron Metabolism and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.91
Funders
- National Natural Science Foundation of China